HDI Publications by date

See all publications >

For HDI publications in association with NDRS, click here.

Using the Search: Choose a publication year, then use search to find papers within that year. No results? The paper may have been published in a different year — try selecting another year and searching again.

U

A registry study of relapsed or refractory multiple myeloma pre-exposed to 3 or more therapies including a proteasome inhibitor, an immunomodulatory agent and cd38-targeted monoclonal antibody therapy in England

Elsada A, Zalin-Miller A, Knott CS, Caravotas L. Abstract: Some patients with multiple myeloma are receiving treatment in clinical practice in England after prior exposure to a proteasome inhibitor, an …

Surgical decisions in older women with early breast cancer: patient and disease factors

Jauhari Y, Gannon MR, Dodwell D, Horgan K, Clements K, Medina J, et al. Abstract: Background Studies reporting lower rates of surgery for older women with early invasive breast cancer have focused on women with …

Significant variation in treatment and survival outcomes in stage 2–4 ovarian cancer in England

Sundar SS, Knott CS, Paley L, et al. Abstract: Introduction/Background Complete cytoreductive surgery and platinum-based chemotherapy is standard of care in the United Kingdom (NICE, 2011), yet studies indicate …

Utilising Public Health England Datasets to Establish a Standing Cohort of Patients with Metastatic Bladder Cancer

Davies FJ. Knott CS, Kerr C, Adedokun L, Lockhat DM. Utilising Public Health England Datasets to Establish a Standing Cohort of Patients with Metastatic Bladder Cancer: Initial Results and Algorithm Defining …

Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane project.

Shaaban AM, Hilton B, Clements K, Provenzano E, Cheung S, Wallis MG, et al. Abstract: Background The Sloane audit compares screen-detected ductal carcinoma in situ (DCIS) pathology with subsequent management and …

Geographic variation in ovarian, fallopian tube and primary peritoneal cancer treatment in England

Ovarian Cancer Audit Feasibility Pilot Steering Group. Geographic variation in ovarian, fallopian tube and primary peritoneal cancer treatment in England. Public Health England, London; November 2020.
No results found.